MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Consolidator ... Mass Market Scale-up, Global Reach, Public Capital
Consolidators: BioPharmaceuticals
Sanofi-Aventis SA (NYSE: SNY)
Finance & Acquisitions: Sanofi
Kymab Group Ltd
Attachments
kymab
Parents
*Architects: Biotechnology _Monoclonal, Polyclonal, Bispecific Antibodies & Antibody-Drug Conjugates (ADC)s
*Industry: United Kingdom - UK (England, Scotland, Wales, Northern Ireland)
2010: FierceBiotech Top 15 Biotechnology Companies (2010)
Companies: Acquired_(M&A)
Finance & Acquisitions: Sanofi
Gates Foundations: Awards & Awardees
Children
2014: Gates Foundation, Wellcome Trust Invest in Kymab Biopharmaceutical Company
2021: Sanofi to acquire Kymab, adding KY1005 to its pipeline, a human monoclonal antibody targeting key immune system regulator OX40L Paris Stock Exchange:SAN
Cambridge, England, United Kingdom
Founded 2010
Kymab, a Sanofi company, has focused on developing its unique antibody platforms to create a portfolio of therapeutics